• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

治疗药物监测和药物遗传学检测作为药物警戒的工具。

Therapeutic drug monitoring and pharmacogenetic tests as tools in pharmacovigilance.

作者信息

Jaquenoud Sirot Eveline, van der Velden Jan Willem, Rentsch Katharina, Eap Chin B, Baumann Pierre

机构信息

Psychiatrische Dienste Aargau AG, MediQ, Klinik Königsfelden, Brugg, Switzerland.

出版信息

Drug Saf. 2006;29(9):735-68. doi: 10.2165/00002018-200629090-00001.

DOI:10.2165/00002018-200629090-00001
PMID:16944962
Abstract

Therapeutic drug monitoring (TDM) and pharmacogenetic tests play a major role in minimising adverse drug reactions and enhancing optimal therapeutic response. The response to medication varies greatly between individuals, according to genetic constitution, age, sex, co-morbidities, environmental factors including diet and lifestyle (e.g. smoking and alcohol intake), and drug-related factors such as pharmacokinetic or pharmacodynamic drug-drug interactions. Most adverse drug reactions are type A reactions, i.e. plasma-level dependent, and represent one of the major causes of hospitalisation, in some cases leading to death. However, they may be avoidable to some extent if pharmacokinetic and pharmacogenetic factors are taken into consideration. This article provides a review of the literature and describes how to apply and interpret TDM and certain pharmacogenetic tests and is illustrated by case reports. An algorithm on the use of TDM and pharmacogenetic tests to help characterise adverse drug reactions is also presented. Although, in the scientific community, differences in drug response are increasingly recognised, there is an urgent need to translate this knowledge into clinical recommendations. Databases on drug-drug interactions and the impact of pharmacogenetic polymorphisms and adverse drug reaction information systems will be helpful to guide clinicians in individualised treatment choices.

摘要

治疗药物监测(TDM)和药物遗传学检测在最大程度减少药物不良反应及增强最佳治疗反应方面发挥着重要作用。个体对药物的反应因遗传构成、年龄、性别、合并症、包括饮食和生活方式(如吸烟和饮酒)在内的环境因素以及诸如药代动力学或药效学药物相互作用等与药物相关的因素而有很大差异。大多数药物不良反应为A型反应,即与血浆水平相关,是导致住院的主要原因之一,在某些情况下可导致死亡。然而,如果考虑药代动力学和药物遗传学因素,在一定程度上这些不良反应可能是可以避免的。本文对文献进行了综述,并描述了如何应用和解读TDM及某些药物遗传学检测,并通过病例报告进行说明。还提出了一个关于使用TDM和药物遗传学检测来帮助确定药物不良反应特征的算法。尽管在科学界,药物反应差异越来越受到认可,但迫切需要将这一知识转化为临床建议。药物相互作用数据库以及药物遗传学多态性的影响和药物不良反应信息系统将有助于指导临床医生进行个体化治疗选择。

相似文献

1
Therapeutic drug monitoring and pharmacogenetic tests as tools in pharmacovigilance.治疗药物监测和药物遗传学检测作为药物警戒的工具。
Drug Saf. 2006;29(9):735-68. doi: 10.2165/00002018-200629090-00001.
2
[Recommendations for therapeutic monitoring of antidepressants].[抗抑郁药治疗监测的建议]
Rev Med Suisse. 2013 Mar 13;9(377):577-86.
3
Pharmacogenetic testing and therapeutic drug monitoring are complementary tools for optimal individualization of drug therapy.药物遗传学检测和治疗药物监测是优化药物治疗个体化的互补工具。
Eur J Clin Pharmacol. 2010 Aug;66(8):755-74. doi: 10.1007/s00228-010-0857-7. Epub 2010 Jun 27.
4
Can pharmacogenetics help rescue drugs withdrawn from the market?药物遗传学能帮助挽救已退市的药物吗?
Pharmacogenomics. 2006 Sep;7(6):889-908. doi: 10.2217/14622416.7.6.889.
5
Pharmacogenetic aspects of drug-induced torsade de pointes: potential tool for improving clinical drug development and prescribing.药物诱导的尖端扭转型室性心动过速的药物遗传学方面:改善临床药物开发和处方的潜在工具。
Drug Saf. 2004;27(3):145-72. doi: 10.2165/00002018-200427030-00001.
6
Pharmacogenetics: the therapeutic drug monitoring of the future?药物遗传学:未来的治疗药物监测?
Clin Pharmacokinet. 2001;40(11):783-802. doi: 10.2165/00003088-200140110-00001.
7
[Therapeutic drug monitoring: A pharmacotherapeutic tool in psychiatry].[治疗药物监测:精神病学中的一种药物治疗工具]
Praxis (Bern 1994). 2006 Apr 26;95(17):671-8. doi: 10.1024/0369-8394.95.17.671.
8
The AGNP-TDM expert group consensus guidelines: therapeutic drug monitoring in psychiatry.AGNP-TDM专家组共识指南:精神科治疗药物监测
Pharmacopsychiatry. 2004 Nov;37(6):243-65. doi: 10.1055/s-2004-832687.
9
[State of the art of pharmacogenetic diagnostics in drug therapy].[药物治疗中药理基因诊断的现状]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2006 Oct;49(10):995-1003. doi: 10.1007/s00103-006-0045-1.
10
AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011.AGNP 精神病治疗药物监测共识指南:2011 年更新版。
Pharmacopsychiatry. 2011 Sep;44(6):195-235.

引用本文的文献

1
Study on the daily dose and serum concentration of clozapine in psychiatric patients and possible influencing factors of serum concentration.精神科患者氯氮平的日剂量与血药浓度研究及血药浓度的可能影响因素。
BMC Psychiatry. 2023 Aug 15;23(1):596. doi: 10.1186/s12888-023-05078-z.
2
Personalizing atomoxetine dosing in children with ADHD: what can we learn from current supporting evidence.为多动症儿童个体化定制托莫西汀剂量:我们能从当前的支持性证据中学到什么。
Eur J Clin Pharmacol. 2023 Mar;79(3):349-370. doi: 10.1007/s00228-022-03449-1. Epub 2023 Jan 16.
3
Simple and Robust Detection of Gene Deletions and Duplications Using as Reference.

本文引用的文献

1
Adverse drug reactions following nonresponse in a depressed patient with CYP2D6 deficiency and low CYP 3A4/5 activity.一名患有CYP2D6缺乏症且CYP 3A4/5活性较低的抑郁症患者在无反应后出现药物不良反应。
Pharmacopsychiatry. 2006 Jul;39(4):150-2. doi: 10.1055/s-2006-946705.
2
Regulation of drug-metabolizing enzymes and transporters in inflammation.炎症中药物代谢酶和转运体的调控
Annu Rev Pharmacol Toxicol. 2006;46:123-49. doi: 10.1146/annurev.pharmtox.46.120604.141059.
3
Methadone enantiomer plasma levels, CYP2B6, CYP2C19, and CYP2C9 genotypes, and response to treatment.
使用 作为参考进行基因缺失和重复的简单且稳健的检测。 (你提供的原文中“using”后面似乎缺少具体内容)
Pharmaceuticals (Basel). 2022 Jan 28;15(2):166. doi: 10.3390/ph15020166.
4
Role of Drug-Gene Interactions and Pharmacogenetics in Simvastatin-Associated Pulmonary Toxicity.药物-基因相互作用和药物遗传学在辛伐他汀相关性肺毒性中的作用。
Drug Saf. 2021 Nov;44(11):1179-1191. doi: 10.1007/s40264-021-01105-8. Epub 2021 Oct 4.
5
Personalized prescribing: a new medical model for clinical implementation of psychotropic drugs.个性化处方:精神药物临床应用的一种新医学模式。
Dialogues Clin Neurosci. 2016 Sep;18(3):313-322. doi: 10.31887/DCNS.2016.18.3/ceap.
6
HLA typing in Brazilian boys with aromatic antiepileptic drug-induced DRESS.巴西芳香族抗癫痫药物诱导的 DRESS 男孩 HLA 分型。
Int J Clin Pharm. 2013 Jun;35(3):319-22. doi: 10.1007/s11096-013-9770-3. Epub 2013 Apr 11.
7
Antiepileptic drug interactions - principles and clinical implications.抗癫痫药物相互作用——原理与临床意义。
Curr Neuropharmacol. 2010 Sep;8(3):254-67. doi: 10.2174/157015910792246254.
8
Pharmacogenetic testing and therapeutic drug monitoring are complementary tools for optimal individualization of drug therapy.药物遗传学检测和治疗药物监测是优化药物治疗个体化的互补工具。
Eur J Clin Pharmacol. 2010 Aug;66(8):755-74. doi: 10.1007/s00228-010-0857-7. Epub 2010 Jun 27.
9
Spontaneous ADR reports as a trigger for pharmacogenetic research: a prospective observational study in the Netherlands.作为药物遗传学研究触发因素的自发药品不良反应报告:荷兰的一项前瞻性观察性研究
Drug Saf. 2009;32(3):255-64. doi: 10.2165/00002018-200932030-00008.
10
Role of cytochrome P450 polymorphisms in the development of pulmonary drug toxicity: a case-control study in the Netherlands.细胞色素P450基因多态性在肺部药物毒性发生中的作用:荷兰的一项病例对照研究
Drug Saf. 2008;31(12):1125-34. doi: 10.2165/0002018-200831120-00008.
美沙酮对映体血浆水平、CYP2B6、CYP2C19和CYP2C9基因型以及治疗反应。
Clin Pharmacol Ther. 2005 Dec;78(6):593-604. doi: 10.1016/j.clpt.2005.08.011.
4
In vitro cytochrome P450 inhibition data and the prediction of drug-drug interactions: qualitative relationships, quantitative predictions, and the rank-order approach.体外细胞色素P450抑制数据与药物相互作用预测:定性关系、定量预测及排序法
Clin Pharmacol Ther. 2005 Dec;78(6):582-92. doi: 10.1016/j.clpt.2005.09.004.
5
Sex differences in antiretroviral therapy-associated intolerance and adverse events.抗逆转录病毒疗法相关不耐受性和不良事件中的性别差异。
Drug Saf. 2005;28(12):1075-83. doi: 10.2165/00002018-200528120-00003.
6
Effects of age and sex on olanzapine plasma concentrations.年龄和性别对奥氮平血浆浓度的影响。
J Clin Psychopharmacol. 2005 Dec;25(6):570-4. doi: 10.1097/01.jcp.0000185427.08268.db.
7
Dose-dependent interaction of paroxetine with risperidone in schizophrenic patients.帕罗西汀与利培酮在精神分裂症患者中的剂量依赖性相互作用。
J Clin Psychopharmacol. 2005 Dec;25(6):527-32. doi: 10.1097/01.jcp.0000185428.02430.c7.
8
Sex differences in the subjective tolerability of antipsychotic drugs.抗精神病药物主观耐受性的性别差异。
J Clin Psychopharmacol. 2005 Dec;25(6):521-6. doi: 10.1097/01.jcp.0000185423.15891.02.
9
Combinatorial pharmacogenetics.组合药物遗传学
Nat Rev Drug Discov. 2005 Nov;4(11):911-8. doi: 10.1038/nrd1874.
10
Predicting in vivo drug interactions from in vitro drug discovery data.从体外药物发现数据预测体内药物相互作用。
Nat Rev Drug Discov. 2005 Oct;4(10):825-33. doi: 10.1038/nrd1851.